Robert B. Hance, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 53,202 shares at $45.49 ($2.4M) on 2011-02-08, disclosed to the SEC on 2011-02-10.
Scheduled sale ($2.4M) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.46 | 25,602 | $1.2M | 48.1% |
| 2 | $45.47 | 9,400 | $427K | 17.7% |
| 3 | $45.47 | 700 | $32K | 1.3% |
| 4 | $45.47 | 7,000 | $318K | 13.2% |
| 5 | $45.47 | 1,500 | $68K | 2.8% |
| 6 | $45.48 | 200 |
| $9K |
| 0.4% |
| 7 | $45.48 | 1,300 | $59K | 2.4% |
| 8 | $45.48 | 4,800 | $218K | 9.0% |
| 9 | $45.49 | 400 | $18K | 0.8% |
| 10 | $45.50 | 2,300 | $105K | 4.3% |
| Total | $45.47 avg | 53,202 | $2.4M | 100% |
| Filing → |
| ABT | SELL | 2012-03-02 | $4.6M | — | Filing → |
| ABT | SELL | 2011-12-16 | $4.2M | — | Filing → |
| ABT | SELL | 2011-03-02 | $75K | — | Filing → |